|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-10-23
|
|
pubmed:abstractText |
Development of insulin resistance (IR) and the progressive failure of the pancreatic beta-cell function (BCF) may be important in the pathogenesis of type 2 diabetes. Influence of peroxisome proliferator-activated receptors ligand bezafibrate on BCF and IR in patients with diabetes is unknown. The present study was aimed to investigate the long-term effect of bezafibrate on these parameters in diabetic patients enrolled in the Bezafibrate Infarction Prevention (BIP) Study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1879-1484
|
|
pubmed:author |
pubmed-author:AdlerYehudaY,
pubmed-author:BeharSolomonS,
pubmed-author:BoykoValentinaV,
pubmed-author:FeinbergMichaM,
pubmed-author:FismanEnrique ZEZ,
pubmed-author:LapidotMordechaiM,
pubmed-author:MatasZiporaZ,
pubmed-author:MotroMichaelM,
pubmed-author:SchwammenthalEhudE,
pubmed-author:TanneDavidD,
pubmed-author:TenenbaumAlexanderA,
pubmed-author:TenenbaumHelenaH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
194
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
265-71
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16970952-Aged,
pubmed-meshheading:16970952-Bezafibrate,
pubmed-meshheading:16970952-Blood Glucose,
pubmed-meshheading:16970952-Diabetes Mellitus, Type 2,
pubmed-meshheading:16970952-Disease Progression,
pubmed-meshheading:16970952-Female,
pubmed-meshheading:16970952-Follow-Up Studies,
pubmed-meshheading:16970952-Homeostasis,
pubmed-meshheading:16970952-Humans,
pubmed-meshheading:16970952-Hypolipidemic Agents,
pubmed-meshheading:16970952-Inflammation,
pubmed-meshheading:16970952-Insulin Resistance,
pubmed-meshheading:16970952-Insulin-Secreting Cells,
pubmed-meshheading:16970952-Lipids,
pubmed-meshheading:16970952-Male,
pubmed-meshheading:16970952-Middle Aged,
pubmed-meshheading:16970952-Placebos
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes.
|
|
pubmed:affiliation |
Endocrinology and Diabetes Unit, Dan-Petah-Tikva District, Clalit Health Services, Israel.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
